MAPT and Alzheimer disease: The two LLD groups exhibited significant differences in all three parameters: the LLD AD group showed significantly lower (p < 0.0001) Aβ42/40 ratio and significantly higher (p < 0.0001) P-tau and T-tau levels than LLD NoAD.